ClinicalTrials.Veeva

Menu

Influence of Local Bone Status on Complications After Surgical Treatment of Proximal Humerus Fractures

A

AO Clinical Investigation and Publishing Documentation

Status

Completed

Conditions

Treatment Complications
Poor Bone Quality
Proximal Humeral Fractures

Study type

Observational

Funder types

Other

Identifiers

NCT01143675
FFOB-Hum

Details and patient eligibility

About

The purpose of this study is to evaluate if poor bone quality increases the risk of specific types of treatment complications in patients with proximal humerus fractures treated with open reduction and angle-stable plates (Proximal Humeral Internal Locking System - PHILOS).

Full description

More than 70% of patients with a proximal humerus fracture are older than 60 years, up to three quarters are women and the incidence of low-energy fractures increases exponentially with age. The standard diagnostic method for classifying osteoporosis is the measurement of Bone Mineral Density at specific body sites - hip, vertebra or distal radius. Despite the fact that osteoporotic fractures are very frequent at the shoulder, no study investigated the correlation between local bone quality and fracture treatment at the proximal humerus.

There is a concern among the clinicians that osteoporotic bone in proximal humerus fractures increases the risk of treatment complications. However, to our knowledge this has not yet been evaluated in clinical studies. One major reason for this lack of studies is the fact that no standardized method exists for the determination of bone density at the proximal humerus.

Enrollment

148 patients

Sex

All

Ages

50 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Radiologically confirmed closed fracture (within 10 days) of the proximal humerus
  • All dislocated (mod. Neer) proximal humerus fractures except dislocated fractures of the greater and lesser tuberosity
  • Primary fracture treatment with a PHILOS-plate
  • Age equal greater than 50 and equal younger than 90 years
  • Normal function of both shoulders (pre-trauma) according to age
  • Monotrauma
  • Willing and able to give written informed consent to participate in the study
  • Willing and able to participate in the study follow-ups according to the CIP
  • Willing and able to comply with the postoperative management program
  • Able to understand and read country national language

Exclusion criteria

  • Open proximal humerus fractures
  • Concomitant contralateral proximal humerus fracture
  • Previous proximal humerus fracture on either side after the age of 25
  • Time to operation > 10 days
  • Polytrauma
  • Cuff-arthropathy of the contralateral proximal humerus
  • Associated nerve or vessel injury
  • Regular systemic therapy with corticosteroids due to chronic disease
  • Legal incompetence
  • Patient received radio- or chemotherapy prior to, during or within the last year
  • Currently active cancer
  • Recent history of substance abuse (i.e. recreational drugs, alcohol)
  • Prisoner
  • Currently involved in a pharmaceutical clinical study§
  • Has a disease process that would preclude accurate evaluation (e.g. neuromuscular or rheumatic disease, significant psychiatric or metabolic disorders)
  • Simultaneous participation in another orthopedic/surgical study with the same or another fracture has to be approved by the AOCID.

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems